More
    Guided Solutions - Connecting Talent With Innovation/div>

    Hyperfine secures $40M loan facility

    Funding
    Horizon Technology Finance Corporation said that it provided a $40 million loan facility to Hyperfine. The loan facility includes an initial funding of $15 million at closing. The remaining $25 million is available to...

    Hyperfine secures $40M loan facility

    Funding
    Horizon Technology Finance Corporation said that it provided a $40 million loan facility to Hyperfine. The loan facility includes an initial funding of $15...

    Meril secures CE mark for MISSO Surgical Robot

    Regulatory Approvals
    Meril Life Sciences has secured CE marking for its MISSO robotic surgical system, a regulatory milestone bringing the platform into compliance with the stringent...

    Providence Medical enrols first patients in CORUS-LX system trial

    Clinical Trials
    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    FDA clears Varian’s TrueBeam systems for low-dose radiation therapy

    Regulatory Approvals
    Varian has received US Food and Drug Administration (FDA) clearance for its TrueBeam radiotherapy systems to use low-dose radiation therapy (LDRT) in adults with...

    Get Weekly Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    Innovation

    Regulatory Approvals

    Hyperfine secures $40M loan facility

    Horizon Technology Finance Corporation said that it provided a $40 million loan facility to Hyperfine. The loan facility includes an initial funding of $15...

    Meril secures CE mark for MISSO Surgical Robot

    Meril Life Sciences has secured CE marking for its MISSO robotic surgical system, a regulatory milestone bringing the platform into compliance with the stringent...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    FDA clears Varian’s TrueBeam systems for low-dose radiation therapy

    Varian has received US Food and Drug Administration (FDA) clearance for its TrueBeam radiotherapy systems to use low-dose radiation therapy (LDRT) in adults with...

    M&A

    Archives

    Latest articles

    Load more

    Popular categories

    Funding1100Regulatory Approvals992Innovation650Clinical Trials512Mergers & Acquisitions496

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices